Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel

AIDS

Volumn 19, Issue 18, 2005, Pages 2157-2163

  Malonza, Isaac M ^a   Mirembe, Florence ^b   Nakabiito, Clemensia ^b   Odusoga, Lawrence O ^c   Osinupebi, Olubunmi A ^c   Hazari, Kamal ^d   Chitlange, Shanta ^d   Ali, Mohamed M ^a   Callahan, Marianne ^e   Van Damme, Lut ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MAKERERE UNIVERSITY   (Uganda)

^c OLABISI ONABANJO UNIVERSITY   (Nigeria)

^d NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Cellulose sulphate; HIV prevention; Microbicide; Phase I clinical trial; Sexually transmitted infections; Vaginal gel

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CELLULOSE SULFATE; CONTRACEPTIVE AGENT; K Y JELLY; UNCLASSIFIED DRUG;

ADNEXA DISEASE; ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; GYNECOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MICROSCOPY; NIGERIA; PAIN; PHASE 1 CLINICAL TRIAL; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SIDE EFFECT; STATISTICAL SIGNIFICANCE; UGANDA; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINA DISEASE; VAGINAL PRURITUS;

EID: 27944510206     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000194797.59046.8f     Document Type: Article

References (9)

1. UNAIDS. 2004 Report on the Global HIV/AIDS Epidemic: 4th Global Report. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2004.
2. Mauck C, Frezieres R, Walsh T, Robergeau K, Callahan M. Cellulose sulfate: tolerance and acceptability of penile application. Contraception 2001; 64:377-381.
3. Anderson RA, Feathergill KA, Diao XH, Cooper MD, Kirkpatrick R, Herold BC, et al. Preclinical evaluation of sodium cellulose sulfate (Ushercell) as a contraceptive antimicrobial agent. J Androl 2002; 23:426-438.
4. Mauck C, Weiner DH, Ballagh S, Creinin M, Archer DF, Schwartz J, et al. Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study. Contraception 2001; 64:383-391.
5. Christensen ND, Reed CA, Culp TD, Hermonat PL, Howett MK, Anderson RA, et al. Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicrob Agents Chemother 2001; 45:3427-3432.
6. Spencer SE, Valentin-Bon IE, Whaley K, Jerse AE. Inhibition of Neisseria gonorrhoeae genital tract infection by leading-candidate topical microbicides in a mouse model. J Infect Dis 2004; 189:410-419.
7. World Health Organization and CONRAD. Manual for the Standardization of Colposcopy for the Evaluation of Vaginal Products, Update 2000. Geneva and Arlington: World Health Organization and CONRAD, 2000.
8. Hardin J, Hible J. Generalized Linear Models and Extensions. College Station, Texas: Stata Press; 2001.
9. StataCorp. Stata Statistical Software: Release 8.0. College Station, Texas: Stata Corporation, 2003.